Skip to main content

Table 1 Characters of included studies

From: Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis

Author

Year

Sample size

Region

Male/female

Experimental intervention

Compare

Outcome

Follow-up#

Massimo Giusti [19]

2016

258

Italy

182/76

Levofloxacin

Prulifloxacin

Clinical cure rates; Relapse of exacerbation; Mortality

1Y

Chin Kook Rhee [20]

2015

345

Korea

312/33

Zabofloxacin

Moxifloxacin

Clinical cure rates; Microbiological response; Adverse effects

36D

Marjolein Brusse-Keizer [21]

2014

35

Netherlands

21/14

Amoxicillin-clavulanic

Placebo

Clinical cure rates; Relapse of exacerbation

4 M

Sevim Uzun [22]

2014

92

Netherlands

NA

Azithromycin

Placebo

Adverse effects

12 M

Holl Yoon [23]

2013

137

Korea

126/11

Levofloxacin

Cefuroxime

Clinical cure rates; Microbiological response; Adverse effects

14D

F.Blasi [24]

2013

357

Italy

222/135

Prulifloxacin

Levofloxacin

Clinical cure rate; Microbiological response; Adverse effects

6 M

Carl Llor [25]

2012

310

Spain

251/59

Amoxicillin-clavulanic

Placebo

Clinical cure rate; Microbiological response; Adverse effects

1Y3M

Robert Wilson [26]

2012

1492

Multicentre

833/659

Moxifloxacin

Amoxicillin-clavulanic

Clinical cure rate; Adverse effects

8 W

Semir Nouira [27]

2010

170

Tunisia

155/15

Trimethoprim-sulfamethoxazole

Ciprofloxacin

Clinical cure rate; Adverse effects; Mortality

6 M

Johannes Daniels [28]

2010

223

Netherlands

133/90

Doxycycline

Placebo

Clinical cure rate; Microbiological response

30D

Carl Llor [29]

2009

137

Spain

109/28

Amoxicillin

Amoxicillin-clavulanic

Clinical cure rate; Adverse effects

30D

Mara Rubia Andre-Alves [30]

2007

102

Brazil

59/43

Azithromycin

Amoxicillin

Clinical cure rate; Adverse effects

30D

Patrick Petitpretz [31]

2007

689

France

476/109

Levofloxacin

cefuroxime

Clinical cure rates; Adverse effects

6 M

H.Lode [32]

2004

511

Germany

277/227

Levofloxacin

Clarithromycin

Clinical cure rate; Microbiological response; Adverse effects

52 W

Ilknur Basyigit [33]

2004

30

Turkey

30/0

Clarithromycin

Placebo

Adverse effect

14D

Richard Castaldo [34]

2003

86

U.S

38/48

Dirithromycin

Azithromycin

Clinical cure rate; Adverse effects

35D

Semir Nouira [35]

2001

93

Tunisia

84/9

Ofloxacin

Placebo

Clinical cure rate; Adverse effects

26D

S.Umut [36]

1999

106

Turkey

91/15

Azithromycin

Ampicillin-sulbactam

Clinical cure rate

10D

     

Ciprofloxacin

Cefaclor

  

L.Allegra [37]

1996

733

France

489/244

Sparfloxacin

Amoxicillin-clavulanic

Clinical cure rate; Adverse effects

24D

  1. #: D day, W week, M Month, Y year